Samples collected under clinical trial parameters and transcriptomic data with matched clinical records and digitized biopsy histopathology are informative for both diagnostic and therapeutic development.
- Biopsy, urine and blood were collected both in the protocol and for-cause settings longitudinally at multiple centers internationally
- The transcriptomic and digitized pathology data are paired with demographic and clinical data along with the local pathology report findings.
- All raw sequencing files and full transcriptome data are maintained in a secure analytics environment on AWS platform.
- The reproducible results of gene counts from these final processes have been thoroughly assessed in product development and demonstrated in analytical validation.
This rich data resource allows immediate access for discovery or validation efforts and supports a strong infrastructure for research and collaboration under properly controlled settings. For more information please contact us at clientservices@vericidx.com
